Five years on since The BMJ's special issue on racism in medicine, and a global pandemic, the landscape is very different, ...

Devyser Diagnostics AB (DVYSR) reported its first profitable quarter as a public company in Q4 2024, with revenue reaching SEK 64.2 million, marking a 41.5% year-over-year increase. This achievement ...

An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.